- $139.34bn
- $148.44bn
- $22.60bn
- 89
- 16
- 95
- 75
Annual income statement for Stryker, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 14,351 | 17,108 | 18,449 | 20,498 | 22,595 |
| Cost of Revenue | |||||
| Gross Profit | 9,110 | 11,001 | 11,637 | 13,099 | 14,519 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 12,128 | 14,520 | 15,608 | 16,610 | 18,906 |
| Operating Profit | 2,223 | 2,588 | 2,841 | 3,888 | 3,689 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,954 | 2,281 | 2,683 | 3,673 | 3,492 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,599 | 1,994 | 2,358 | 3,165 | 2,993 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,599 | 1,994 | 2,358 | 3,165 | 2,993 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,599 | 1,994 | 2,358 | 3,165 | 2,993 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 6.04 | 7.94 | 8.71 | 9.39 | 11.2 |
| Dividends per Share |